What it is
SLU-PP-332 is a peptide supplement that acts as an ERR agonist, researched for its potential as an exercise mimetic. It is formulated to support metabolic and blood-sugar health.
5 mg · vegan · gluten-free · 30 caps
Affiliate link · we earn from qualifying purchases. No paid placements.
SLU-PP-332 is a peptide supplement that acts as an ERR agonist, researched for its potential as an exercise mimetic. It is formulated to support metabolic and blood-sugar health.
This peptide primarily targets the pancreas, liver, and muscle tissue by activating ERR pathways. Effects on metabolic markers are typically observed within 8-12 weeks of consistent use, with outcomes being dose-dependent.
Adults looking to address insulin resistance, weight gain, low energy. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
C · C · emerging-to-moderate human evidence for metabolic and blood-sugar health
SacredBod's longer take on SLU-PP-332 — context the structured blocks above don't capture.
SLU-PP-332 is a peptide supplement used to support metabolic and blood-sugar health. ERR agonist researched as exercise mimetic. It is available in capsule form and dosed for adults in India and internationally. As a peptide-tradition entry in the SacredBod catalog, it is positioned as a single-ingredient option that can be used on its own or layered into a broader protocol. SLU-PP-332 works through the mechanisms characteristic of its class — see the mechanism and research sections for detail. It primarily acts on the pancreas, liver, muscle, and effects are dose-dependent, typically becoming measurable within 8-12 weeks for metabolic markers. Consistency matters more than dose size for this category.
SLU-PP-332 carries an evidence grade of C in the SacredBod catalog, reflecting emerging human evidence for metabolic and blood-sugar health. ERR agonist researched as exercise mimetic. Benefits are cumulative rather than immediate, typically becoming noticeable within 8-12 weeks for metabolic markers, and individual response varies.
A typical dose is 5 mg, taken with food, usually in the morning. Start at the lower end, assess tolerance, and stay consistent; more is not automatically better.
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
Adults looking to address insulin resistance, weight gain, low energy. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
As part of the Peptide category, SLU-PP-332 can be used on its own or layered into a broader protocol — see the Goes with panel for evidence-aligned pairings.
Peptides are physician-only. Tell us a bit and we'll route you to the right specialist.
Request received.
We'll route this to a clinician familiar with peptide protocols. Expect a reply within about 48 hours.
How's your experience? We read every note.